Multiple genetic alterations and behavior of cellular biology in gastric cancer and other gastric mucosal lesions: H. pylori infection, histological types and staging

World Journal of Gastroenterology

Volumn 6, Issue 6, 2000, Pages 848-854

  Gao, H J ^a   Yu, L Z ^a   Bai, J F ^a   Peng, Y S ^a   Sun, G ^a   Zhao, H L ^a   Miu, K ^a   Lu X Z ^a   Zhang, X Y ^a   Zhao, Z Q ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; PROTEIN BCL 2; PROTEIN P16; PROTEIN P53;

ARTICLE; BACTERIAL INFECTION; BEHAVIOR GENETICS; CANCER STAGING; CARCINOGENESIS; CORRELATION FUNCTION; DISEASE ASSOCIATION; DISEASE COURSE; GENE EXPRESSION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; PROTEIN EXPRESSION; STOMACH CANCER; STOMACH MUCOSA LESION;

EID: 0034516932     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v6.i6.848     Document Type: Article

References (71)

1. Adenocarcinoma of the stomach: Are we marking progress?
2. Human gastric carcinogenesis: A multistep and multifactorial process
3. p53 gene mutations in primary gastric cancer
4. Studies on the relationship between the point mutation of ras oncogenes and the prognosis of patients with gastric cancer
5. Expression of bcl-2 protein in gastric carcinoma and its significance
6. Research on p53 gene mutation of biopsy samples from stomach cancer patients
7. Oncogene ras, c-myc mRNA expression in gastric carcinoma and its clinical significance
8. Relationship between P53, nm23 protein expression and lymphatic hyperplasia in gastric cancer
9. Expression of Span-1 and Ypan-1 in gastric cancer and subtypes of intestinal metaplasia
10. 44v6 protein expression in gastric carcinoma and precancerous lesions
11. MUC2 gene expression in gastric cancer and preneoplastic lesion tissues
12. Helicobacter pylori and cell proliferation of the gastric mucosa: Possible implications for gastric carcinogenesis
13. AgNOR and rasp21 expression in gastric mucosal lesions with Helicobacter pylori infection
14. Biological behavior of type III intestinal metaplasia and dysplasia with Helicobacter pylori infection
15. Effect of Helicobacter pylori infection on gastric epithelial proliferation in progression from normal mucosa to gastriccarcinoma
16. Relationship between Hp infection and oncogene and tumor suppressor gene expressions in gastric cancer and precancerosis
17. PCNA and c-erbB-2 expression in gastric mucosal intestinal metaplasia with Helicobacter pylori infection
18. Study on Helicobacter pylori infection and p53, c-erbB-2 gene expression in carcinogenesis of gastric mucosa
19. Effect of Hp infection on gastric epithelial cell kinetics in stomach diseases
20. Longterm effects of concentrated Helicobacter pylori culture supernatant on gastric mucosa of rats
21. Infection of Helicobacter pylorus and proliferation and apoptosis of gastric mucosa epithelium
22. Helicobacter pylori infection and risk of gastric cancer in Changle County, Fujian Province, China
23. Research of Helicobacter pylori infection in precancerous gastric lesions
24. Effect of Helicobacter pylori infection on gastric epithelial cell proliferation
25. Overexpression of mutant p53 and c-erbB-2 proteins and mutations of the p15 and p16 genes in human gastric carcinoma: With respect to histological subtypes and stages
26. Helicobacter pylori induces apoptosis in gastric mucosa through an upregulation of Bax expression in humans
27. Expression of Bcl-2 in autoimmune and Helicobacter pylori-associated atrophic gastritis
28. Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis
29. Cyclooxygenase 2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infection
30. In situ hybridization of P53 tumor suppressor gene in human gastric precancerous lesions and gastric cancer
31. The two histological main types of gastric carcinoma diffuse and so-called intestinal type carcinoma
32. Molecular mechanism of stomach carcinogenesis
33. Kinetic patterns of advanced gastric cancer as related to histotype and tumor extension
34. Overexpression p53 predicts shorter survival in diffuse type gastric cancer
35. Alterations of the p16/ MTS1-tumor suppressor gene in gastric cancer
36. Prognostic value of Bcl-2 expression in gastric cancer
37. Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma
38. Clinical significance of expressions of P16, P53 proteins and PCNA in gastric cancer
39. Role of DNA aneuploidy, overexpression of p53 gene product, and cellular proliferation in the progression of gastric cancer
40. Cooccurrence of reduced expression of alpha-cetenin and overexpression of p53 is a predictor of lymph node metastasis in early gastric cancer
41. Molecular biology and gastric carcinoma
42. Missense mutations and deletion of the p53 gene in human gastric cancer
43. Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas
44. Suppression of human colorectal cell growth by wild-type p53
45. Wild-type p53 is a cell cycle check point determinant following irradiation
46. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
47. Studies on p53 and nm23-H1 mRNA expression genes in hepatocellular carcinoma
48. A cell cycle regulator potentially involved in genesis of many tumor types
49. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/ CDK4
50. Alteration of p15 and p16 gene in gastric cancer
51. Frequent detection of aberrant RNA transcripts of the CDKN2 gene in human gastric adenocarcinoma
52. Study of the relationship between apoptosis and proliferation in gastric carcinoma and its precancerous lesion
53. Bcl-2 initiates a new category of oncogenes: Regulators of cell death
54. Expressions of p53 bcl-2 and c-erbB-2 proteins in precarcinomatous gastric mucosa
55. Effects of NSAIDs on proliferation of gastric cancer cells in vitro: Possible implication of cyclooxygenase-2 in cancer development
56. Induction of gastric epithelial apoptosis by Helicobacter pylori
57. Gastric carcinoma
58. Expression of tumor suppressive gene and regulatory gene of apoptosis in gastric mucosal lesions and gastric cancer with Helicobacter pylori infection
59. Genetic alterations in gastric cancer: Relation to histological subtypes, tumor stage, and Helicobacter pylori infection
60. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer
61. Prognostic value of p53 protein expression for patients with gastric cancer- A multivariate analysis
62. The pattern of p53 oncoprotein expression in gastric cancer patients
63. P53 overexpression in gastric adenocarcinoma with Helicobacter pylori infection
64. Mutations of the p53 suppressor gene in gastric adenocarcinoma
65. Implications of p53 mutation spectrum for cancer etiology in gastric cancers of various histologic types from a high-risk area of central Italy
66. Bcl-2 expression as a prognostic factor of survival of gastric carcinoma
67. Immunohistochemical analysis of Bcl-2 family proteins in adenocarcinomas of the stomach
68. Infrequent alterations of the p16 (MTS-1) gene in human gastric cancer
69. Deletion and down-regulation of mts1/ p16 gene in human gastric cancer
70. Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice
71. The expression and mutual relationship of p53, p16, and Bcl-2 proteins in gastric carcinoma and surrounding tissues